A detailed history of Y Intercept (Hong Kong) LTD transactions in Ocugen, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 164,354 shares of OCGN stock, worth $118,334. This represents 0.01% of its overall portfolio holdings.

Number of Shares
164,354
Holding current value
$118,334
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$0.72 - $1.08 $118,334 - $177,502
164,354 New
164,354 $131,000
Q1 2024

May 10, 2024

BUY
$0.5 - $1.83 $64,412 - $235,749
128,825 New
128,825 $211,000
Q2 2023

Aug 14, 2023

SELL
$0.45 - $0.88 $36,135 - $70,664
-80,300 Reduced 36.21%
141,491 $76,000
Q1 2023

May 09, 2023

BUY
$0.82 - $1.33 $181,868 - $294,982
221,791 New
221,791 $188,000
Q4 2022

Feb 14, 2023

SELL
$1.11 - $1.87 $37,781 - $63,649
-34,037 Closed
0 $0
Q3 2022

Feb 14, 2023

BUY
$1.75 - $3.1 $59,564 - $105,514
34,037 New
34,037 $60,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $156M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.